Study Evaluating AMG 706 in Subjects with Advanced Solid Tumors

Sponsor ID

20030116

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

This study will determine the safety and pharmacokinetics of AMG 706 in subjects with advanced solid tumors.

Phase

Phase 1

Product

motesanib diphosphate

Type

Interventional

Masking

None (Open Label)

Enrollment

Additional Study Details

Primary Outcome Measures

Timeframe: Cycle 1

Secondary Outcome Measures

Timeframe: Study completion

No locations found.